Your browser doesn't support javascript.
loading
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study.
Huang, J; Zhang, X-H; Cai, Y; Yang, D; Shi, J; Xing, P; Xu, T; Wu, L; Su, W; Xu, R; Wei, T; Chen, H-J; Yang, J-J.
Afiliação
  • Huang J; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Zhang XH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Cai Y; Medical Oncology Department V, Guangdong Nongken Central Hospital, Zhanjiang, China.
  • Yang D; The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
  • Shi J; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Xing P; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu T; The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Wu L; The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • Su W; Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Xu R; Department of Oncology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
  • Wei T; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Chen HJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: yangjinji@gdph.org.cn.
Clin Oncol (R Coll Radiol) ; 36(1): 39-45, 2024 01.
Article em En | MEDLINE | ID: mdl-37977903
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article